ArticleFrontiers in medicine2025
Factors influencing therapeutic efficacy of non-lactational mastitis based on hematological inflammatory markers and establishment of a predictive model.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore factors influencing the therapeutic efficacy of non-lactational mastitis (NLM) based on hematological inflammatory markers and to establish a predictive model. Methods: Two hundred and sixty-four cases of NLM patients admitted to The Fourth People's Hospital of Zhenjiang and Changzhou Maternal and Child Health Care Hospital from January 2019 to December 2022 were retrospectively selected. The patients were divided into a modeling group ( Results: The results of binary logistics regression analysis showed that SII and CRP were influencing factors of therapeutic efficacy of NLM ( Conclusion: SII and CRP are influencing factors of therapeutic efficacy of NLM. This study successfully established a prediction model based on hematological inflammatory markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.